Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fareon Open Label Device Clinical Trial
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.
Official title: Microtesla Magnetic Therapy (MMT) Treatment of Cognitive Impairment: Open Label Pilot Study
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-05-01
Completion Date
2027-04-30
Last Updated
2026-05-20
Healthy Volunteers
No
Interventions
Fareon device
Participants will use the device 2 times per week for 15 minutes at home.
Locations (1)
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
New York, New York, United States